Massachusetts General Hospital
Neurotherapeutics
The Neurotherapeutics Ecosystem at Mass General
Learn more about our neurotherapeutics ecosystem. Here you will find our clinical and research endeavors that show the breadth and depth of the neurotherapies across Mass General.
Neurological Clinical Research Institute (NCRI)
The NCRI develops, designs, supports and manages innovative observational and interventional trials for neurological disorders.
Clinical Trials Network and Institute (CTNI)
The CTNI offers psychiatric services that include site selection for your clinical trials, establish scientific advisory boards, assist in POC trial designs and review clinical developmental plans.
Clinical and Translational Research Unit
The mission of the CTRU is to dramatically transform clinical research to accelerate progress in the prevention, management and cure of complex brain disorders.
Mass General's neurotherapeutic development research program is situated among one of the world’s largest neuroscience, clinical and biotech communities.
Unparalleled Research Capabilities
We push scientific boundaries by training the best minds in the world
Massachusetts Biotech Ecosystem
Worlds largest concentration of biotechnology and research centers.
Mass General has 1,200 clinical trials taking place at any given time.
Electroconvulsive Therapy (ECT) for Depression
Are you planning on receiving ECT treatments for depression? Are you interested in getting an MRI scan of your brain? If you answered yes, you may be eligible for our study.
Low Field Magnetic Stimulation
Investigating a novel treatment for bipolar depression in older adults aged 55 and older.
Neuroimaging Study of Chronic Low Back Pain
Recruiting subjects and healthy volunteers for a research study to understand the epigenetic changes in the brains of patients with chronic low back pain.
Support Mass General Neurotherapeutics
Massachusetts General Hospital Neuroscience clinical trials seeks to prevent and treat brain based diseases while advancing the development of novel therapies.